The US White House has informed governors to prepare for vaccination of children from five years from next month in anticipation of approval of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine for the age group in the coming weeks.
Already the Biden administration has bought 65 million pediatric doses of the vaccine, which is enough to vaccinate around 28 million kids who will be eligible once the FDA approves the vaccine for children between 5 and 11 years.
Drugmakers aren’t doing enough to end the coronavirus pandemic
Pfizer and Moderna (NASDAQ: MRNA) have been doing an excellent job in the fight against the pandemic. Their CEOs are will receive the Edward M. Kennedy Institute Award for Inspired Leaders for creating the coronavirus vaccines. Moderna CEO Stephane Bancel and Pfizer’s CEO Albert Bourla will receive the award on December 2, 2021.
Drug companies are in the race to end the Coronavirus pandemic, but their failure to ramp up manufacturing could prolong the pandemic and cost lives. The only way to avert this is by having the Pfizer, and Moderna duopoly is broken in mRNA vaccine production. As a result, people are receiving less effective vaccines or whose protection wanes against variants which means more booster doses and selling of vaccines to countries depending on ability to pay and not need. For the companies that have distributed almost 1 billion doses between them, it means more business.
The US donates Pfizer vaccine to Nigeria.
The US government is donating 3.5 million Pfizer vaccine doses to Nigeria. A White House official said, “We are sharing these doses not to secure favors or extract concessions. Our vaccines do not come with strings attached. We are doing this with the singular objective of saving lives.”
Panama approved Pfizer’s COVID-19 booster vaccine for high-risk individuals, including hospitalized patients, healthcare providers, people above 55, and nursing home residents.
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. While reading this article one must assume that we may be compensated for posting this content on our website.